New Blood Thinners Will Prevent Blood Clots Without Causing Bleeding
Several blood thinners are being developed that could prevent the clots that cause heart attacks and strokes—without some of the side effects.
Several blood thinners are being developed that could prevent the clots that cause heart attacks and strokes—without some of the side effects.
One of the major determinants of exercise intolerance and limiting symptoms among patients with obstructive hypertrophic cardiomyopathy (HCM) is an elevated intracardiac pressure resulting from…
Show Hematopoiesis: An ASH Trainee Council Production, Ep Celebrating Pride Month with Career Development Advice for LGBTQ+ Hematology Trainees – May 10, 2024
This EACCME-accredited webinar will cover chronic kidney disease in cardio-renal-metabolic patients and management in primary care.
Dr. Hilary Cass published a landmark report that led to restrictions on youth gender care in Britain. U.S. health groups said it did not change…
Abstract. Glucocorticoids are widely prescribed as anti-inflammatory and immunosuppressive agents. This results in at least 1% of the population using chro
Inotuzumab ozogamicin (INO) is an anti-CD22 antibody-drug conjugate that was first evaluated in B-cell lymphomas but was subsequently shown to be highly effective in acute…
“In my late 20s, I started to have thoughts that people were out to get me. As the paranoia increased, I stopped eating and sleeping.”
In June of each year, hematology trainees from across Canada gather in Toronto, Ontario for the National Hematology Resident Retreat. This event spans a weekend…
With surgeries crumbling, demand rising, and more patient abuse, many family doctors are experiencing breakdowns – and, devastatingly, worse
To explore innovative approaches, technologies, and strategies to cure advanced cancers, the Stanford Cancer Institute hosted a group of nationally recognized cancer experts on the…